Literature DB >> 4656352

Mycoplasmacidal activity of peroxidase-H2O2-halide systems.

A A Jacobs, I E Low, B B Paul, R R Strauss, A J Sbarra.   

Abstract

A mycoplasmacidal system consisting of myeloperoxidase (MPO)-containing granules, H(2)O(2), and a halide is described. In all parameters measured, it appears to be identical to the MPO-H(2)O(2)-halide bactericidal system previously reported. It has a pH optimum of approximately 5.5 and an optimal MPO:H(2)O(2) ratio of 1:25. The halide requirement can be satisfied by either chloride or iodide. Through the use of taurine or horseradish peroxidase substitution, chloride-mediated killing can be distinguished from iodide-mediated killing. The relationship of this mycoplasmacidal system to other mycoplasmacidal systems and to host surveillance of mycoplasma is discussed.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4656352      PMCID: PMC422332          DOI: 10.1128/iai.5.1.127-131.1972

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  32 in total

1.  A CLINICAL REPORT ON CASES OF PRIMARY ATYPICAL PNEUMONIA CAUSED BY A NEW VIRUS.

Authors:  G Meiklejohn; M D Eaton; W van Herick
Journal:  J Clin Invest       Date:  1945-03       Impact factor: 14.808

2.  Peroxidase-mediated virucidal systems.

Authors:  M E Belding; S J Klebanoff; C G Ray
Journal:  Science       Date:  1970-01-09       Impact factor: 47.728

3.  The role of the phagocyte in host-parasite interactions. 13. The direct quantitative estimation of H2O2 in phagocytizing cells.

Authors:  B Paul; A J Sbarra
Journal:  Biochim Biophys Acta       Date:  1968-02-01

4.  Mycoplasma hominis and abortion.

Authors:  H J Harwick; R H Purcell; J B Iuppa; F R Fekety
Journal:  J Infect Dis       Date:  1970-03       Impact factor: 5.226

5.  Birth weight and genital mycoplasmas in pregnancy.

Authors:  P Braun; Y H Lee; J O Klein; S M Marcy; T A Klein; D Charles; P Levy; E H Kass
Journal:  N Engl J Med       Date:  1971-01-28       Impact factor: 91.245

6.  Mycoplasmacidal action of normal tissue extracts.

Authors:  E Kaklamanis; L Thomas; K Stavropoulos; I Borman; C Boshwitz
Journal:  Nature       Date:  1969-03-01       Impact factor: 49.962

7.  Antifungal effects of peroxidase systems.

Authors:  R I Lehrer
Journal:  J Bacteriol       Date:  1969-08       Impact factor: 3.490

8.  Relation of catalase to substrate utilization by Mycoplasma pneumoniae.

Authors:  I E Low; M D Eaton; P Proctor
Journal:  J Bacteriol       Date:  1968-04       Impact factor: 3.490

9.  Function of h(2)o(2), myeloperoxidase, and hexose monophosphate shunt enzymes in phagocytizing cells from different species.

Authors:  B B Paul; R R Strauss; A A Jacobs; A J Sbarra
Journal:  Infect Immun       Date:  1970-04       Impact factor: 3.441

10.  Phagocytin: a bactericidal substance from polymorphonuclear leucocytes.

Authors:  J G HIRSCH
Journal:  J Exp Med       Date:  1956-05-01       Impact factor: 14.307

View more
  6 in total

1.  Myeloperoxidase of polymorphonuclear leukocytes in psoriasis vulgaris.

Authors:  H Greiten; M Rister; G K Steigleder
Journal:  Arch Dermatol Res       Date:  1987       Impact factor: 3.017

2.  Enzyme activity of salivary lactoperoxidase adsorbed to human enamel.

Authors:  K M Pruitt; M Adamson
Journal:  Infect Immun       Date:  1977-07       Impact factor: 3.441

3.  Plant chemiluminescence.

Authors:  F B Abeles
Journal:  Plant Physiol       Date:  1978-11       Impact factor: 8.340

4.  Degradation of thyroid hormones by phagocytosing human leukocytes.

Authors:  S J Klebanoff; W L Green
Journal:  J Clin Invest       Date:  1973-01       Impact factor: 14.808

5.  Myeloperoxidase deficiency: an epidemiological study and flow-cytometric detection of other granular enzymes in myeloperoxidase-deficient subjects.

Authors:  R Becker; K H Pflüger
Journal:  Ann Hematol       Date:  1994-10       Impact factor: 3.673

6.  Oxidative peptide cleavage and decarboxylation by the MPO-H2O2-Cl- antimicrobial system.

Authors:  R J Selvaraj; B B Paul; R R Strauss; A A Jacobs; A J Sbarra
Journal:  Infect Immun       Date:  1974-02       Impact factor: 3.441

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.